Medulloblastomas (MB), the most common malignant pediatric brain tumors, mainly show somatic heterozygous missense mutations of SMARCA4, which are suggested to have a dominant-negative effect resulting in a loss of function [15, 29, 44, 55]. This evidence concerns the gene SMARCA4 and brain neoplasm.